Brittany Robinson, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 3519 Paesanos Pkwy Ste 105, Shavano Park, TX 78231 Phone: 210-481-4265 Fax: 210-851-8374 |
News Archive
After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, according to a study by researchers at UC San Francisco.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, will update preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy in a poster titled "ADXS11-001 immunotherapy targeting HPV-E7: Preliminary survival data from a phase II study in Indian women with recurrent/refractory cervical cancer" at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, on Sunday, June 3, 2012.
AIBioTech is pleased to announce implementation of a new laboratory derived test to measure L-asparaginase levels in patients being treated with any of the current asparaginase drugs including: Oncaspar, Kidrolase, Erwinaze, and Elspar.
To improve the quality and safety of healthcare in the United States, the National Quality Forum is releasing its updated manual Safe Practices for Better Healthcare. The 34 Safe Practices outlined in the manual are tools to prevent healthcare errors and address common issues like healthcare-associated infections, medication errors, surgical errors, and pressure ulcers
› Verified 8 days ago